Eukles Asset Management’s Inozyme Pharma INZY Stock Holding History

Eukles Asset Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$4K	–	241
2025 Q2	$4K	Buy	+1,000	New	+$2.48K	﹤0.01%	191

Eukles Asset Management's INZY Position: Q3 2025 in Review

Eukles Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 1,000 shares — an estimated $4K sold.

Eukles Asset Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $4K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Eukles Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Eukles Asset Management sold 1,000 Inozyme Pharma shares in Q3 2025, an estimated $4K.
Eukles Asset Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Eukles Asset Management's Inozyme Pharma position peaked at $4K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Eukles Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.